Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat

Clinical and Experimental Metastasis

Volumn 16, Issue 2, 1998, Pages 169-177

  Himelstein, Bruce P ^a   Lee, Edward J ^a   Sato, Hiroshi ^b   Seiki, Motoharu ^b   Muschel, Ruth J ^c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell cell contact; Metastasis; Meyalloproteinases; Transcription

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL INTERACTION; EMBRYO; ENZYME INDUCTION; ENZYME LOCALIZATION; FIBROBLAST; GENE EXPRESSION REGULATION; METASTASIS POTENTIAL; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE REPEAT; PROMOTER REGION; RAT; TRANSCRIPTION REGULATION;

EID: 0031747428     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006576305405     Document Type: Article

References (35)

1. Goldberg G and Eisen A, 1991, Extracellular matrix metalloproteinases in tumor invasion and metastasis. In: Lippmann M and Dickson R, eds. Regulatory Mechanisms in Breast Cancer. Kluwer Academic Publishers: Boston, pp. 421-40.
2. Liotta L, Steeg P and Stetler-Stevenson W, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36.
3. Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW and Muschel RJ, 1995, Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metast, 1-6, 246-58.
4. Zeng ZS and Guillem JG, 1995, Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer, 72, 575-82.
5. Gress TM, Muller PF, Lerch MM, Friess H, Buchler M and Adler G, 1995, Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer, 62, 407-13.
6. Urbanski S, Edwards D, Maitland A, Leco K, Watson A and Kossakowska A, 1992, Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer, 66, 1188-92.
7. Canete-Soler R, Litsky L, Lubensky I and Muschel R, 1994, Localization of the 92 kDa gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol, 144, 518-27.
8. Pyke C, Ralfkiaer E, Tryggvason K and Dano K, 1993, Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol, 142, 359-65.
9. Nielsen B, Timshel S, Kjeldsen L, et al. 1996, 92 kDa Type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer, 65, 57-62.
10. Karelina T, Hruza G, Goldberg G and Eisen A, 1992, Localization of 92 kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin. J Invest Dermatol, 100, 159-65.
11. Davies B, Waxman J, Wasan H, et al. 1993, Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res, 53, 5365-9.
12. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res, 50, 3872-7.
13. Himelstein B, Canete-Soler R, Bernhard E and Muschel R, 1994, Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci, 107, 477-86.
14. Xia Y, Garcia G, Chen S, Wilson C and Feng L, 1996, Cloning of rat 92-kDa type IV collagenase and expression of an active recombinant catalytic domain. FEBS Lett, 382, 285-8.
15. Masure S, Nys G, Fiten P, Van DJ and Opdenakker G, 1993, Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. Eur J Biochem, 218, 129-41.
16. Fini M, Bartlett J, Matsubara M, et al. 1994, The rabbit gene for 92-kDa matrix metalloproteinase. J Biol Chem, 269, 28620-8.
17. Huhtala P, Chow L and Tryggvason K, 1990, Structure of the human type IV collagenase gene. J Biol Chem, 265, 11077-82.
18. Sato H and Seiki M, 1993, Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395-405.
19. Sato H, Kita M and Seiki M, 1993, v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. J Biol Chem, 268, 23460-8.
20. Gum R, Lengyel E, Juarez J, et al. 1996, Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem, 271, 10672-80.
21. Gustin K and Burk R, 1993, A rapid method for generating linker scanning mutants utilizing PCR. BioTechniques, 14, 22-3.
22. Schreiber E, Matthias P, Muller MM and Schaffner W, 1989, Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res, 17, 6419.
23. Higashino F, Yoshida K, Noumi T, Seiki M and Fujinaga K, 1995, Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene, 10, 1461-3.
24. Gutman A and Wasylyk B, 1990, The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J, 9, 2241-6.
25. Nerlov C, Rorth P, Blasi F and Johnsen M, 1991, Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene, 6, 1538-42.
26. Rorth P, Nerlov C, Blasi F and Johnsen M, 1990, Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acid Res, 18, 5009-17.
27. Buttice G, Quinones S and Kurkinen M, 1991, The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene. Nucleic Acids Res, 19, 3723-31.
28. Buttice G and Kurkinen M, 1993, A polyomavirus enhancer A-binding protein-3 site and ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. J Biol Chem, 268, 7196-204.
29. Philips N, Bashey R and Jimenez S, 1995, Increased α1(I) procollagen gene expression in tight skin (TSK) mice myocardial fibroblasts is due to a reduced interaction of a negative regulatory sequence with AP-1 transcription factor. J Biol Chem, 270, 9313-21.
30. Katai H, Stephenson J, Simkevich C, Thompson J and Raghow R, 1992, An AP-1-like motif in the first intron of human Proα1(I) collagen gene is a critical determinant of its transcriptional activity. Mol Cell Biochem, 118, 119-29.
31. Harendza S, Pollock A, Mertens P and Lovett D, 1995, Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem, 270, 18786-96.
32. Tripathi J and Brahmachari S, 1991, Distribution of simple repetitive (TG/CA)n and (CT/AG)n sequences in human and rodent genomes. J Biomol Struct Dyn, 9, 387-97.
33. Wu T, Ikezono T, Angus C and Shelhamer J, 1994, Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene. Nucleic Acids Res, 22, 5093-8.
34. Yu M and Edenberg H, 1995, Structure and function of a long alternating purine-pyrimidine sequence in the mouse alcohol dehydrogenase Adh-1 gene. Arch Biochem Biophys, 316, 407-12.
35. Herrick K, Gorin F, Park E and Tait R, 1993, Characterization of the 5' flanking region of the gene encoding rat liver glycogen phosphorylase. Gene, 126, 203-11.